Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) CFO Jeffrey Trigilio sold 1,920 shares of the company’s stock in a transaction on Thursday, December 21st. The shares were sold at an average price of $8.50, for a total transaction of $16,320.00. Following the completion of the sale, the chief financial officer now directly owns 83,919 […]
Related Keywords
United States , Jeffrey Trigilio , Algert Global , Citigroup Inc , Annandale Capital , Cullinan Oncology Inc , Schonfeld Strategic Advisors , Cullinan Oncology Company Profile , Tower Research Capital , Nasdaq , Cullinan Oncology , Get Free Report , Oncology Stock Down , Strategic Advisors , Research Capital , Cullinan Oncology Daily , Nasdaq Cgem , Cgem , Medical , Insider Trading , Nsider Trades , Stocks ,
comparemela.com © 2020. All Rights Reserved.